ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

COVAX expects full vaccine supplies from India's Serum in May

A man reacts as he receives a dose of COVISHIELD, a COVID-19 vaccine manufactured by Serum Institute of India at a temporary vaccination center in Ahmedabad, India, March 26.   © Reuters

NEW DELHI (Reuters) -- A World Health Organization (WHO)-backed program to supply coronavirus vaccines to poorer countries expects that the Serum Institute of India (SII) will resume full deliveries of the AstraZeneca shot to it in May, UNICEF said on Saturday.

"Deliveries of SII/AZ vaccine are expected to begin fully again by May, with catch-up deliveries to reach every participant's full allocation up to May, accelerating thereafter," a UNICEF spokeswoman told Reuters in an email.

The spokeswoman added that the program, known as COVAX, was in talks with New Delhi to secure "some supply" in April too. COVAX was expecting a total of 90 million doses from SII in March and April, of which it has received about 28 million.

UNICEF is the distributing partner of the program, run with the GAVI vaccine alliance.

India, the world's biggest vaccine maker, said on Friday it would make domestic COVID-19 inoculations a priority as infections surge, and had told international buyers of its decision.

WHO Director-General Tedros Adhanom Ghebreyesus said on Friday that India's decision was "understandable" but that the WHO was in talks so it continues providing doses to other countries.

So far COVAX has delivered 32 million vaccine doses to 61 countries, but 36 countries still await vaccines to start inoculations, Tedros said.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more